KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History → Did Intel Just Dethrone Nvidia? (From Chaikin Analytics) (Ad) Free KALV Stock Alerts $12.49 +0.49 (+4.08%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability KalVista Pharmaceuticals Stock Price Performance5 Day Performance+3.31%1 Month Performance+5.05%3 Month Performance-13.26%6 Month Performance+60.54%Year-To-Date Performance+1.96%1 Year Performance+27.58% Receive KALV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsMy system predicted the BA collapse – now it’s issuing an AI warningEven after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... KALV Stock Chart for Tuesday, May, 14, 2024 KALV Chart by TradingView KalVista Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$12.08$12.00-0.66%$12.43$11.91206,932 shs$506.28 million05/10/2024$12.09$12.08-0.08%$12.15$11.79217,887 shs$509.63 million05/09/2024$12.06$12.09+0.25%$12.21$11.98128,987 shs$510.05 million05/08/2024$12.19$12.06-1.07%$12.25$12.00160,775 shs$508.81 million05/07/2024$12.14$12.19+0.41%$12.28$11.97131,214 shs$514.30 million05/06/2024$12.13$12.14+0.08%$12.22$12.02193,066 shs$512.19 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$12.17$12.13-0.33%$12.48$11.96199,656 shs$511.77 million05/02/2024$12.18$12.17-0.08%$12.30$11.78571,496 shs$513.45 million05/01/2024$11.35$12.18+7.31%$12.52$11.35482,057 shs$513.87 million04/30/2024$11.01$11.35+3.09%$11.40$10.92321,782 shs$478.86 million04/29/2024$10.78$11.01+2.13%$11.19$10.88194,250 shs$464.51 million04/26/2024$10.49$10.78+2.76%$10.81$10.27241,417 shs$454.81 million04/25/2024$10.35$10.49+1.35%$10.52$10.11363,774 shs$442.57 million04/24/2024$11.21$10.35-7.67%$11.18$10.32482,316 shs$436.67 million04/23/2024$11.44$11.21-2.01%$11.71$11.19192,444 shs$472.95 million04/22/2024$11.57$11.44-1.12%$11.78$11.36289,249 shs$482.65 million04/19/2024$11.50$11.57+0.61%$11.78$11.27346,976 shs$488.14 million04/18/2024$11.65$11.50-1.29%$11.75$11.28408,653 shs$485.19 million04/17/2024$11.88$11.65-1.94%$11.94$11.65298,645 shs$491.51 million04/16/2024$11.74$11.88+1.19%$12.16$11.48489,733 shs$501.22 million04/15/2024$11.89$11.74-1.26%$12.01$11.50313,460 shs$495.31 million04/12/2024$12.10$11.89-1.74%$12.05$11.70237,891 shs$501.64 million04/11/2024$11.93$12.10+1.42%$12.26$11.71312,126 shs$510.48 million04/10/2024$11.81$11.93+1.02%$11.94$11.37554,624 shs$503.30 million04/09/2024$11.04$11.81+6.97%$11.85$11.02571,645 shs$498.26 million04/08/2024$11.09$11.04-0.45%$11.20$10.82210,204 shs$465.78 million04/05/2024$11.21$11.09-1.07%$11.38$10.97184,357 shs$467.89 million04/04/2024$11.26$11.21-0.44%$11.42$10.95500,277 shs$472.95 million04/03/2024$11.04$11.26+1.99%$11.34$10.81220,866 shs$475.06 million04/02/2024$11.40$11.04-3.16%$11.48$10.921.47 million shs$465.78 million04/01/2024$11.86$11.40-3.88%$11.79$11.03817,261 shs$480.97 million03/29/2024$11.86$11.86$12.46$10.922.15 million shs$500.37 million03/28/2024$11.07$11.86+7.14%$12.46$10.922.15 million shs$500.37 million03/27/2024$11.11$11.07-0.36%$11.41$10.97266,044 shs$467.04 million03/26/2024$11.13$11.11-0.18%$11.38$10.70520,288 shs$468.73 million03/25/2024$11.85$11.13-6.08%$11.84$11.04514,062 shs$499.93 million03/22/2024$12.15$11.85-2.47%$12.29$11.75270,704 shs$499.95 million03/21/2024$12.23$12.15-0.65%$12.70$12.07280,289 shs$512.61 million03/20/2024$11.84$12.23+3.29%$12.24$11.75446,784 shs$515.98 million03/19/2024$11.99$11.84-1.25%$12.38$11.65454,865 shs$499.53 millionHUGE BUY ALERT: Move Fast, Musk... (Ad)I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix.03/18/2024$11.93$11.99+0.50%$12.35$11.58560,270 shs$505.86 million03/15/2024$12.43$11.93-4.02%$12.56$11.87792,468 shs$503.33 million03/14/2024$12.49$12.43-0.48%$12.57$12.12458,750 shs$429.58 million03/13/2024$12.49$12.49$12.78$12.42408,314 shs$431.65 million03/12/2024$13.10$12.49-4.66%$13.07$12.31570,981 shs$431.65 million03/11/2024$14.36$13.10-8.77%$14.44$13.06664,015 shs$452.72 million03/08/2024$14.01$14.36+2.53%$14.52$13.771.22 million shs$496.28 million03/07/2024$14.38$14.01-2.61%$14.45$12.871.13 million shs$484.01 million03/06/2024$13.98$14.38+2.86%$14.62$14.05562,586 shs$496.97 million03/05/2024$14.03$13.98-0.36%$14.21$13.86434,316 shs$483.15 million03/04/2024$14.14$14.03-0.78%$14.27$13.86414,160 shs$484.88 million03/01/2024$13.65$14.14+3.59%$14.28$13.68501,947 shs$488.68 million02/29/2024$13.39$13.65+1.94%$13.81$13.43628,636 shs$471.74 million02/28/2024$14.62$13.39-8.41%$14.64$13.32960,533 shs$462.76 million02/27/2024$13.69$14.62+6.79%$14.80$13.821.04 million shs$505.27 million02/26/2024$12.58$13.69+8.82%$13.76$12.72964,478 shs$473.11 million02/23/2024$12.58$12.58$12.70$11.951.30 million shs$434.77 million02/22/2024$13.04$12.58-3.53%$13.11$12.481.27 million shs$434.77 million02/21/2024$13.80$13.04-5.51%$13.89$13.031.01 million shs$450.66 million02/20/2024$14.86$13.80-7.13%$14.78$13.611.38 million shs$476.93 million02/19/2024$14.86$14.86$15.00$14.311.21 million shs$513.56 million02/16/2024$14.76$14.86+0.68%$15.00$14.311.21 million shs$513.55 million02/15/2024$14.40$14.76+2.50%$16.88$14.657.34 million shs$510.11 million02/14/2024$14.85$14.40-3.03%$15.25$14.371.57 million shs$497.66 million02/13/2024$16.04$14.85-7.42%$16.13$13.264.46 million shs$513.22 million Related Companies: TVTX Stock Price Chart ALT Stock Price Chart OCS Stock Price Chart VERV Stock Price Chart STTK Stock Price Chart LRMR Stock Price Chart ANL Stock Price Chart CMPS Stock Price Chart ABUS Stock Price Chart ATXS Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHow to Make 100X on the AI BoomInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.